BMS-299897

SynDRA canonical compound SYN0063086 — structure-anchored drug synonym record

Clinical phase	Phase 1
Mechanism of action	gamma secretase inhibitor

Mechanisms of action (all sources)

gamma-secretase inhibitor

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

PTPN1
PTPN2
PTPRC

Cross-references

PubChem CID: 11249248
ChEMBL: CHEMBL247471
ChEBI: 94983
LINCS BRD: BRD-K02950022

Synonyms

RefChem:912039
QK855F579S
C24H21ClF3NO4S
UNII-QK855F579S
orb1707537
SCHEMBL6394108
SCHEMBL29401583
CHEBI:94983
GLXC-02832
EX-A7260
BDBM50477339
MFCD12963627
NSC762672
AKOS024457319
CCG-222540
CS-1339
NSC-762672
NCGC00346875-01
NCGC00346875-03
HY-50883
MS-29503
F84933
T14673
BRD-K02950022-001-01-1
BRD-K02950022-001-02-9
4-[2-[(1R)-1-(N-(4-chlorophenyl)sulfonyl-2,5-difluoroanilino)ethyl]-5-fluorophenyl]butanoic acid
DB-017854
SCHEMBL22694951

Look up BMS-299897 in the interactive SynDRA portal →